• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION TACTRA MALLEABLE PENILE PROTHESIS; PROSTHESIS PENILE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION TACTRA MALLEABLE PENILE PROTHESIS; PROSTHESIS PENILE Back to Search Results
Model Number 720081-01
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problem Deformity/ Disfigurement (2360)
Event Date 07/24/2020
Event Type  Injury  
Manufacturer Narrative
As the complaint component was not returned for analysis, no product analysis could be performed.The reported allegations could not be confirmed.If the complaint component is returned at a later date then the product investigation can be re-opened to perform the analysis.A review of the tactra hazard analysis was completed.Device too long is included as a hazard and therapeutic response, altered is included as a harm, although the appropriate hazardous situation could not be identified with the limited information provided.Based on this review, this complaint does not represent a new or unanticipated event.A labeling review was performed and according to the dfu, implantation of a penile prosthesis may result in penile shortening, curvature, or scarring.Is included in the warnings section.Also there is no evidence that the device was used or handled improperly.A review of manufacturing documentation was performed to ensure that all required in-process and final inspections and testing were completed.Review of the manufacturing records found no evidence that the device failed to meet applicable product specifications prior to shipment from boston scientific.
 
Event Description
It was reported that following implant, the patient implanted with this tactra malleable penile prosthesis presented with curvature of the penis.The physician determined the device was oversized.A surgical procedure was performed wherein the device was removed and reinserted without the need for a new device.No additional patient complications were reported.Additional information was received specifying the curvature was observed mid-shaft of the penis due to the device length being too long for the patient.The device was removed, a portion trimmed from the length, and then reinserted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACTRA MALLEABLE PENILE PROTHESIS
Type of Device
PROSTHESIS PENILE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
10700 bren road w
minnetonka MN 55343
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
alyson harris
10700 bren road w
minnetonka, MN 55343
4089353452
MDR Report Key10379855
MDR Text Key202049520
Report Number2183959-2020-03299
Device Sequence Number1
Product Code FAE
UDI-Device Identifier08714729979357
UDI-Public08714729979357
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183619
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 08/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number720081-01
Device Catalogue Number720081-01
Device Lot Number0024903568
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/24/2020
Initial Date FDA Received08/07/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/01/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age63 YR
-
-